How industry is using technology during the COVID-19 pandemic
The use of technology in its many forms was a recurring theme in BioPhorum’s recent COVID-19 Workforce Protection Survey that was completed by the Senior BioPhorum Connect group, which consists of the leaders and spons...
New risk-based deviation management system can save members an average of 22,200 hours per site
Under a traditional deviation management system (DMS), all events are considered equal and usually require a 30-day clos...
BioPhorum strengthens supply chain resilience through digitization of the supply chain and alternatives to gamma sterilization
Since 2016, BioPhorum Supply Partner has made great progress in bringing together manufacturers and supply partners to b...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
Single-use: Testing, validation and release (TVR) standards
When testing single-use items, at what point is it appropriate to leverage vendor data, and when does an end user need t...
How to make single-use systems supply chain proof?
In the second half of 2020, BioPhorum Drug Substance will publish a comprehensive set of tools and guidance to hel...
Making and moving operational cell banks
Moving the site of manufacture for commercial cell banks, microbial or mammalian, the renewal of working cell banks for ...
Avoiding the rabbit holes: how to develop successful ILM-RTRT strategies
Reducing the time-to-release for drug product is a key goal of the industry as it can lower production costs and acceler...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
New disinfectant efficacy approach saves member $1.5m through stronger compliance
Cleaning and disinfection are crucial during the drug manufacturing process. However, while these tasks support the cont...
Shared clean-in-place systems: to share or not to share?
The risk of viral contamination is acknowledged when developing biopharmaceutical products derived from mammalian-cell c...
A risk-based approach to second person verification in microbial testing
Ensuring the integrity of microbiological test data is fundamental to drug product quality and patient safety. The FDA...
How industry is using technology during the COVID-19 pandemic
The use of technology in its many forms was a recurring theme in BioPhorum’s recent COVID-19 Workforce Protection Surv...
New risk-based deviation management system can save members an average of 22,200 hours per site
Under a traditional deviation management system (DMS), all events are considered equal and usually require a 30-day clos...
BioPhorum strengthens supply chain resilience through digitization of the supply chain and alternatives to gamma sterilization
Since 2016, BioPhorum Supply Partner has made great progress in bringing together manufacturers and supply partners to b...
How is industry responding to the covid-19 pandemic?
During the covid-19 pandemic, it is even more important that we connect, share information and help each other meet the ...
Interested in being a BioPhorum peer reviewer?
Excellence has always been at the heart of everything we do – from holding face-to-face meetings to publishing technic...
Single-use: Testing, validation and release (TVR) standards
When testing single-use items, at what point is it appropriate to leverage vendor data, and when does an end user need t...
How to make single-use systems supply chain proof?
In the second half of 2020, BioPhorum Drug Substance will publish a comprehensive set of tools and guidance to hel...
Making and moving operational cell banks
Moving the site of manufacture for commercial cell banks, microbial or mammalian, the renewal of working cell banks for ...
Avoiding the rabbit holes: how to develop successful ILM-RTRT strategies
Reducing the time-to-release for drug product is a key goal of the industry as it can lower production costs and acceler...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
New disinfectant efficacy approach saves member $1.5m through stronger compliance
Cleaning and disinfection are crucial during the drug manufacturing process. However, while these tasks support the cont...
Shared clean-in-place systems: to share or not to share?
The risk of viral contamination is acknowledged when developing biopharmaceutical products derived from mammalian-cell c...
